Clinical trial METASUN UCL-ONCO 2012-09
A proof of concept study to evaluate the use of metabonomics and lipidomics in predicting toxicity and efficacy of anti-VEGF therapy in patients with metastatic clear cell renal cell carcinoma
Cancers | |
---|---|
Organ | Kidney |
Trial status | Trial open for recruitment |
Investigator | |
Trial type |
Interventional with experimental drug
|
Academic trial | Oui |
Sponsor | UCL St Luc |
EudraCT Identifier | 2011-006085-40 |
ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT02570789 |
Inclusion criteria | Metastatic. RECIST v1.1 |
Last update |